-
ISMPP EU- Our collaborative effort wins ‘Best original research prize’ ie not just a pretty poster.
#ISMPP14AM Same poster wins ‘Best visual communication prize’ I e Yes it is also a very pretty poster! Thank you voters. Congrats co-authors -
Converting @
#ISMPP14AM. Don’t be left behind.#envisionpharmapic.twitter.com/1FMNxjjwZ8
-
Our colleague Hilary Gentile brings
#ISMPP14AM home with an inspirational keynote on The Truth About Doctors pic.twitter.com/afRTh93hsH
-
Impact Factor has real business implications for journals. “Your manuscript is not high enough quality” may be editor-speak for not likely to be well cited
#ISMPP14AM -
Helping patients access peer-reviewed pubs for free via
#OpenAccess is a benefit of OA. Strong interest from publication professionals in sharing publications with non-academic authors - assuming that group includes patients! Sorry for pic quality but numbers are there#ISMPP14AM pic.twitter.com/IVoQdZ8Mxt
-
Members of the ISMPP Global Transparency & Trends Committee interacting with meeting attendees.
#ISMPP14AM pic.twitter.com/CPii1yr6fw
-
But the nice graph that
@KWProScribe likes would be this one. As@statsguyuk says, correlation does not equal causation, but@GAPPTeam started in 2012 - just saying@caudex_medical Insight Engine#ISMPP14AM pic.twitter.com/eEbbHjjr00
-
Having a great time at ISMPP. Do come and see us at booth #23 !!
#ISMPP14AM pic.twitter.com/t4gY06HMWh
-
Hilary Gentile from @mccann_health takes the stage to deliver today’s keynote presentation. We want to know the truth about doctors!
#ISMPP14AM pic.twitter.com/56YPykitfK
-
Great to catch up with the CMC boys. You can always rely on them to have a drink at the ready!
#ISMPP14AM pic.twitter.com/x7lA5HD7C6
-
Should we, can we post
#preprints for pharma research, and at which phase? The view from#ISMPP14AM pic.twitter.com/K4Bvl75RnR
-
Our very own
@garyburd is moderating a parallel session to help us deal with rejection... Therapy and self-help are included!#ISMPP14AM -
“Group therapy” in Journal Rejections session with
@garyburd — you are not alone!#ISMPP14AM pic.twitter.com/qQiGWOy9ow
-
Thank you very much to our committees, faculty, exhibitors, sponsors, media partners, and attendees for an excellent 14th Annual Meeting of ISMPP! We hope you join us next year!
#ISMPP14AM pic.twitter.com/psRM6L4ykF
-
For those discussing visual enhancements at
#ISMPP14AM this week... https://twitter.com/BJSM_BMJ/status/991882183164997633 …
-
Read Heather Lang’s great presentation
#ISMPP14AM on the current involvement of pharma authors in preprints, here: http://www.healthsciencelive.com/UK/522594 pic.twitter.com/4L2vByim3X
-
#ISMPP14AM Troubling statistics on the impact of caring for patients on a doctor's personal life pic.twitter.com/1X0fgUCdjx
-
Now I know you've *all* been waiting for this - given that I do it at every conference I attend - and I mustn't disappoint...
#pinksocks#ISMPP14AM @ataxiaandme@OxPharmaGenesispic.twitter.com/YBBUxn2gWd
-
I've been using the
@caudex_medical Insight Engine to monitor the "industry ghostwriting" literature. Here are a few simple stats. Sentiment analysis shows that since 1995 most articles have been negative, but year on year, the number of negative articles is falling#ISMPP14AM pic.twitter.com/X6ApmY7EOa
-
#ISMPP14AM the importance of adding the NCT # in the abstract of a clinical trial publications -- "news you can use" session pic.twitter.com/2czrZ8SUAx
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.